Assessing individual head and neck squamous cell carcinoma patient response to therapy through integration of functional and genomic data
Even though head and neck squamous cell carcinoma (HNSCC) is the seventh most common cancer worldwide, there are only two PD-1 targeted immunotherapies (pembrolizumab and nivolumab) and one tumor intrinsic EGFR targeted therapy (cetuximab) that are FDA approved for treatment of HNSCC. Taking advanta...
Uložené v:
| Vydané v: | Scientific reports Ročník 15; číslo 1; s. 19742 - 14 |
|---|---|
| Hlavní autori: | , , , , , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
London
Nature Publishing Group UK
05.06.2025
Nature Publishing Group Nature Portfolio |
| Predmet: | |
| ISSN: | 2045-2322, 2045-2322 |
| On-line prístup: | Získať plný text |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Abstract | Even though head and neck squamous cell carcinoma (HNSCC) is the seventh most common cancer worldwide, there are only two PD-1 targeted immunotherapies (pembrolizumab and nivolumab) and one tumor intrinsic EGFR targeted therapy (cetuximab) that are FDA approved for treatment of HNSCC. Taking advantage of a high throughput inhibitor assay and computational tools originally showing success in leukemia, we designed and employed HNSCC-specific inhibitor panels that capture the diversity of aberrational pathways in HNSCC to test viable cells derived from patients’ HNSCC tumors. This provides a functional context to the multi-omic readouts conducted on these samples (mutations, protein expression and copy number alterations). In addition to generating these deeply characterized functional genomics datasets, we also developed additional visual analytics that have the potential to provide greater insight into HNSCC drug response patterns and potentially aid precision oncology tumor boards in evaluation and assessment of effective targeted therapeutic agents. |
|---|---|
| AbstractList | Even though head and neck squamous cell carcinoma (HNSCC) is the seventh most common cancer worldwide, there are only two PD-1 targeted immunotherapies (pembrolizumab and nivolumab) and one tumor intrinsic EGFR targeted therapy (cetuximab) that are FDA approved for treatment of HNSCC. Taking advantage of a high throughput inhibitor assay and computational tools originally showing success in leukemia, we designed and employed HNSCC-specific inhibitor panels that capture the diversity of aberrational pathways in HNSCC to test viable cells derived from patients’ HNSCC tumors. This provides a functional context to the multi-omic readouts conducted on these samples (mutations, protein expression and copy number alterations). In addition to generating these deeply characterized functional genomics datasets, we also developed additional visual analytics that have the potential to provide greater insight into HNSCC drug response patterns and potentially aid precision oncology tumor boards in evaluation and assessment of effective targeted therapeutic agents. Abstract Even though head and neck squamous cell carcinoma (HNSCC) is the seventh most common cancer worldwide, there are only two PD-1 targeted immunotherapies (pembrolizumab and nivolumab) and one tumor intrinsic EGFR targeted therapy (cetuximab) that are FDA approved for treatment of HNSCC. Taking advantage of a high throughput inhibitor assay and computational tools originally showing success in leukemia, we designed and employed HNSCC-specific inhibitor panels that capture the diversity of aberrational pathways in HNSCC to test viable cells derived from patients’ HNSCC tumors. This provides a functional context to the multi-omic readouts conducted on these samples (mutations, protein expression and copy number alterations). In addition to generating these deeply characterized functional genomics datasets, we also developed additional visual analytics that have the potential to provide greater insight into HNSCC drug response patterns and potentially aid precision oncology tumor boards in evaluation and assessment of effective targeted therapeutic agents. Even though head and neck squamous cell carcinoma (HNSCC) is the seventh most common cancer worldwide, there are only two PD-1 targeted immunotherapies (pembrolizumab and nivolumab) and one tumor intrinsic EGFR targeted therapy (cetuximab) that are FDA approved for treatment of HNSCC. Taking advantage of a high throughput inhibitor assay and computational tools originally showing success in leukemia, we designed and employed HNSCC-specific inhibitor panels that capture the diversity of aberrational pathways in HNSCC to test viable cells derived from patients' HNSCC tumors. This provides a functional context to the multi-omic readouts conducted on these samples (mutations, protein expression and copy number alterations). In addition to generating these deeply characterized functional genomics datasets, we also developed additional visual analytics that have the potential to provide greater insight into HNSCC drug response patterns and potentially aid precision oncology tumor boards in evaluation and assessment of effective targeted therapeutic agents.Even though head and neck squamous cell carcinoma (HNSCC) is the seventh most common cancer worldwide, there are only two PD-1 targeted immunotherapies (pembrolizumab and nivolumab) and one tumor intrinsic EGFR targeted therapy (cetuximab) that are FDA approved for treatment of HNSCC. Taking advantage of a high throughput inhibitor assay and computational tools originally showing success in leukemia, we designed and employed HNSCC-specific inhibitor panels that capture the diversity of aberrational pathways in HNSCC to test viable cells derived from patients' HNSCC tumors. This provides a functional context to the multi-omic readouts conducted on these samples (mutations, protein expression and copy number alterations). In addition to generating these deeply characterized functional genomics datasets, we also developed additional visual analytics that have the potential to provide greater insight into HNSCC drug response patterns and potentially aid precision oncology tumor boards in evaluation and assessment of effective targeted therapeutic agents. |
| ArticleNumber | 19742 |
| Author | Mathieson, Chase Laderas, Ted Anderson, Ashley Evans, Nathaniel Zheng, Christina McWeeney, Shannon Bottomly, Daniel Jeng, Sophia Blucher, Aurora Vigoda, Myles Kulesz-Martin, Molly Lesch, Aletha Jacobs, James |
| Author_xml | – sequence: 1 givenname: Daniel surname: Bottomly fullname: Bottomly, Daniel organization: OHSU Knight Cancer Institute – sequence: 2 givenname: Chase surname: Mathieson fullname: Mathieson, Chase organization: OHSU School of Dentistry – sequence: 3 givenname: Myles surname: Vigoda fullname: Vigoda, Myles organization: Michigan State University College of Osteopathic Medicine – sequence: 4 givenname: Sophia surname: Jeng fullname: Jeng, Sophia organization: OHSU Knight Cancer Institute – sequence: 5 givenname: Nathaniel surname: Evans fullname: Evans, Nathaniel organization: OHSU Knight Cancer Institute – sequence: 6 givenname: Ashley surname: Anderson fullname: Anderson, Ashley organization: Program in Biomedical Sciences, Anesthesiology and Perioperative Medicine, School of Medicine, Oregon Health & Science University – sequence: 7 givenname: Aurora surname: Blucher fullname: Blucher, Aurora organization: Recursion Pharmaceuticals – sequence: 8 givenname: Aletha surname: Lesch fullname: Lesch, Aletha organization: Department of Dermatology, Oregon Health & Science University – sequence: 9 givenname: Christina surname: Zheng fullname: Zheng, Christina organization: OHSU Knight Cancer Institute – sequence: 10 givenname: Ted surname: Laderas fullname: Laderas, Ted organization: Fred Hutch Cancer Center – sequence: 11 givenname: James surname: Jacobs fullname: Jacobs, James organization: Randall Children’s Cancer and Blood Disorders Program at Legacy Emmanuel – sequence: 12 givenname: Molly surname: Kulesz-Martin fullname: Kulesz-Martin, Molly organization: OHSU Knight Cancer Institute, Department of Dermatology, Oregon Health & Science University, Department of Cell, Developmental and Cancer Biology, Oregon Health & Science University – sequence: 13 givenname: Shannon surname: McWeeney fullname: McWeeney, Shannon email: mcweeney@ohsu.edu organization: OHSU Knight Cancer Institute, Division of Bioinformatics and Computational Biology, Department of Medical Informatics and Clinical Epidemiology, Oregon Health & Science University, Division of Oncological Sciences, Oregon Health & Science University |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/40473660$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9ks1u1TAQhSNUREvpC7BAltiwCfgvibOsKmgrVWIDa2tiT3J9SezUTpD6CH1rfG9KQSzwZsbWN2fs8XldnPjgsSjeMvqRUaE-JcmqVpWUVyUVjLGyeVGccSqrkgvOT_7KT4uLlPY0r4q3krWvilNJZSPqmp4Vj5cpYUrOD8R56346u8JIdgiWgLfEo_lB0v0KU1gTMTiOxEA0zocJyAyLQ7-QiGkOPiFZAll2GGF-yDGGddhl0QWHmMHgSehJv3pzyHOPg_yAWcgZYmGBN8XLHsaEF0_xvPj-5fO3q5vy7uv17dXlXWmkUEvZ1LKVHSJXFqr8RiZZ13CrFPK66WkLIIUBzhRj1rRG1nVLGW8U7TueN0qcF7ebrg2w13N0E8QHHcDp40GIg4a4ODOirqiQVoouV6EEXilulKwa0XSygo6KrPVh05pjuF8xLXpy6TAl8JgHpgVntai5lG1G3_-D7sMa8yCOVKWUYFRm6t0TtXYT2ufr_f6wDPANMDGkFLF_RhjVB2PozRg6G0MfjaGbXCS2opRhP2D80_s_Vb8AIau5dA |
| Cites_doi | 10.1038/nature11003 10.1186/gb-2010-11-3-r25 10.1038/s41598-021-94259-5 10.1101/2020.07.25.20146431v1 10.1186/s12943-023-01846-3 10.1371/journal.pcbi.1001057 10.1038/s41586-020-2308-7 10.18637/jss.v046.i11 10.1007/s10147-021-01949-1 10.1038/srep36158 10.1101/2024.12.05.24318538 10.3389/fgene.2019.00004 10.1093/bioinformatics/btp616 10.1038/s41586-018-0623-z 10.1038/nature11005 10.18632/oncotarget.25436 10.1016/j.cell.2018.03.035 10.1093/annonc/mdq588 10.1186/1471-2105-14-144 10.2202/1544-6115.1128 10.1158/0008-5472.CAN-12-1906 10.3389/fphar.2019.00557 10.1126/scitranslmed.3010564 10.3390/cancers12092691 10.1038/nm.3388 10.1016/S1535-6108(04)00112-6 10.1371/journal.pone.0056823 10.1093/bioinformatics/btw538 10.1056/NEJMoa1602252 10.1080/21655979.2021.1957754 10.18632/oncotarget.26559 10.1186/s12864-017-3658-x 10.1186/s13059-016-0974-4 10.1371/journal.pone.0223639 10.1101/gr.1239303 10.1038/s41419-019-1769-9 10.1038/nature12634 10.1056/NEJMoa0802656 10.1186/s13059-019-1758-4 10.1038/nrg.2017.38 10.1093/biostatistics/kxj037 10.1371/journal.pcbi.1000117 10.1186/gb-2006-7-s1-s4 10.1002/0471142905.hg0720s76 10.1038/nature14129 10.1038/s41586-018-0409-3 10.1093/nar/gkv1222 10.1016/j.cels.2020.04.007 10.12688/f1000research.4431.2 10.1158/0008-5472.CAN-06-0186 10.1016/j.cels.2015.12.004 10.1093/nar/gks1111 10.1038/s41467-019-10148-6 10.1101/mcs.a005439 10.1093/bioinformatics/btt003 10.1007/978-1-62703-125-7_11 10.1038/nbt.2514 10.1073/pnas.1009843107 10.3390/cancers17030548 10.1007/s00405-005-0961-y 10.1016/j.ccell.2022.07.002 10.1016/j.ctrv.2020.101977 10.1016/j.crmeth.2021.100039 10.1038/s41572-020-00224-3 10.1016/j.tips.2017.08.006 10.1158/1535-7163.MCT-17-0733 10.1089/omi.2011.0118 10.1056/NEJMp1607591 10.1002/ijc.28112 10.1016/j.cell.2016.06.017 10.1093/nar/gkg509 |
| ContentType | Journal Article |
| Copyright | The Author(s) 2025 2025. The Author(s). Copyright Nature Publishing Group 2025 |
| Copyright_xml | – notice: The Author(s) 2025 – notice: 2025. The Author(s). – notice: Copyright Nature Publishing Group 2025 |
| DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88A 88E 88I 8FE 8FH 8FI 8FJ 8FK ABUWG AEUYN AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M2P M7P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS Q9U 7X8 DOA |
| DOI | 10.1038/s41598-025-03111-7 |
| DatabaseName | SpringerOpen Free (Free internet resource, activated by CARLI) CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Medical Database (Alumni Edition) Science Database (Alumni Edition) ProQuest SciTech Collection ProQuest Natural Science Collection ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) One Sustainability ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central ProQuest Health & Medical Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences ProQuest Health & Medical Collection Medical Database Science Database Biological Science Database ProQuest Central Premium ProQuest One Academic ProQuest Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) One Applied & Life Sciences ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Central China ProQuest Biology Journals (Alumni Edition) ProQuest Central ProQuest One Applied & Life Sciences ProQuest One Sustainability ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Central Basic ProQuest Science Journals ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic CrossRef Publicly Available Content Database |
| Database_xml | – sequence: 1 dbid: DOA name: Acceso a contenido Full Text - Doaj url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: PIMPY name: ProQuest Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Biology |
| EISSN | 2045-2322 |
| EndPage | 14 |
| ExternalDocumentID | oai_doaj_org_article_5034d43b683e4a2582c845737b45ab03 40473660 10_1038_s41598_025_03111_7 |
| Genre | Journal Article |
| GrantInformation_xml | – fundername: National Cancer Institute grantid: T32 CA106195; T32 CA106195; R01 CA192405 funderid: https://doi.org/10.13039/100000054 – fundername: NCI NIH HHS grantid: T32 CA106195 – fundername: NCI NIH HHS grantid: P30 CA069533 – fundername: NCI NIH HHS grantid: P30 CA016672 – fundername: NIH HHS grantid: S10 OD034224 – fundername: NCI NIH HHS grantid: R01 CA192405 |
| GroupedDBID | 0R~ 4.4 53G 5VS 7X7 88E 88I 8FE 8FH 8FI 8FJ AAFWJ AAJSJ AAKDD AASML ABDBF ABUWG ACGFS ACUHS ADBBV ADRAZ AENEX AEUYN AFKRA AFPKN ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BBNVY BCNDV BENPR BHPHI BPHCQ BVXVI C6C CCPQU DIK DWQXO EBD EBLON EBS ESX FYUFA GNUQQ GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE KQ8 LK8 M1P M2P M7P M~E NAO OK1 PHGZM PHGZT PIMPY PMFND PQQKQ PROAC PSQYO RNT RNTTT RPM SNYQT UKHRP AAYXX AFFHD CITATION PJZUB PPXIY PQGLB CGR CUY CVF ECM EIF NPM 3V. 7XB 88A 8FK K9. M48 PKEHL PQEST PQUKI PRINS Q9U 7X8 PUEGO |
| ID | FETCH-LOGICAL-c438t-76494bee28da5204141b72d88e267f09aa43ca21811dc9c4669012780fb246683 |
| IEDL.DBID | DOA |
| ISICitedReferencesCount | 0 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001504112500010&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 2045-2322 |
| IngestDate | Fri Oct 03 12:52:53 EDT 2025 Fri Sep 05 15:57:20 EDT 2025 Tue Oct 07 08:06:59 EDT 2025 Thu Nov 20 01:45:39 EST 2025 Sat Nov 29 07:52:39 EST 2025 Fri Jun 06 04:21:49 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Multi-Omics Antitumor drug screening assays HNSCC |
| Language | English |
| License | 2025. The Author(s). |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c438t-76494bee28da5204141b72d88e267f09aa43ca21811dc9c4669012780fb246683 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| OpenAccessLink | https://doaj.org/article/5034d43b683e4a2582c845737b45ab03 |
| PMID | 40473660 |
| PQID | 3215883104 |
| PQPubID | 2041939 |
| PageCount | 14 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_5034d43b683e4a2582c845737b45ab03 proquest_miscellaneous_3216362449 proquest_journals_3215883104 pubmed_primary_40473660 crossref_primary_10_1038_s41598_025_03111_7 springer_journals_10_1038_s41598_025_03111_7 |
| PublicationCentury | 2000 |
| PublicationDate | 2025-06-05 |
| PublicationDateYYYYMMDD | 2025-06-05 |
| PublicationDate_xml | – month: 06 year: 2025 text: 2025-06-05 day: 05 |
| PublicationDecade | 2020 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England |
| PublicationTitle | Scientific reports |
| PublicationTitleAbbrev | Sci Rep |
| PublicationTitleAlternate | Sci Rep |
| PublicationYear | 2025 |
| Publisher | Nature Publishing Group UK Nature Publishing Group Nature Portfolio |
| Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group – name: Nature Portfolio |
| References | 3111_CR9 MJ Landrum (3111_CR60) 2016; 44 KD Hunter (3111_CR42) 2006; 66 F Ghasemi (3111_CR22) 2018; 9 JW Tyner (3111_CR39) 2013; 73 L Cowen (3111_CR76) 2017; 18 3111_CR3 3111_CR2 3111_CR4 JW Tyner (3111_CR19) 2018; 562 MD Robinson (3111_CR63) 2010; 11 P Bose (3111_CR8) 2013; 133 3111_CR49 3111_CR47 RR Haraksingh (3111_CR43) 2017; 18 RL Ferris (3111_CR15) 2016; 375 G Yu (3111_CR68) 2012; 16 RL Grossman (3111_CR26) 2016; 375 D Bottomly (3111_CR40) 2013; 29 U Ben-David (3111_CR44) 2018; 560 WE Johnson (3111_CR64) 2007; 8 M Tahara (3111_CR14) 2021; 26 J Harrow (3111_CR73) 2006; 7 MS Lawrence (3111_CR17) 2015; 517 3111_CR52 3111_CR53 E Alsahafi (3111_CR5) 2019; 10 JB Vermorken (3111_CR12) 2008; 359 3111_CR59 3111_CR55 3111_CR13 F Iorio (3111_CR37) 2016; 166 C Rasmussen (3111_CR48) 2013; 945 Y Yu (3111_CR32) 2021; 12 P Langfelder (3111_CR66) 2011; 7 D Bottomly (3111_CR61) 2022; 40 W McLaren (3111_CR56) 2016; 17 AS Blucher (3111_CR50) 2017; 38 P Shannon (3111_CR79) 2003; 13 M Mayrhofer (3111_CR71) 2016; 6 CR Chong (3111_CR11) 2013; 19 F Sanchez-Vega (3111_CR34) 2018; 173 W Yang (3111_CR35) 2012; 41 3111_CR29 A Liberzon (3111_CR30) 2015; 1 3111_CR67 A Barsouk (3111_CR1) 2023; 11 N Gavrielatou (3111_CR16) 2020; 84 DE Johnson (3111_CR6) 2020; 6 HJ Aarstad (3111_CR7) 2006; 263 SR Chamberlin (3111_CR51) 2019; 10 H Najgebauer (3111_CR36) 2020; 10 K Tuomainen (3111_CR24) 2021; 11 D Otasek (3111_CR80) 2019; 20 C Kandoth (3111_CR25) 2013; 502 PC Ng (3111_CR58) 2003; 31 S Horvath (3111_CR31) 2008; 4 3111_CR74 3111_CR75 MD Robinson (3111_CR62) 2010; 26 V Walter (3111_CR27) 2013; 8 KJ Karczewski (3111_CR57) 2020; 581 O Jonas (3111_CR46) 2015; 7 3111_CR70 T Lepikhova (3111_CR23) 2018; 17 K Liu (3111_CR45) 2019; 10 J Barretina (3111_CR20) 2012; 483 3111_CR38 P Van Loo (3111_CR72) 2010; 107 3111_CR77 G Wu (3111_CR41) 2014; 3 K Cibulskis (3111_CR54) 2013; 31 N Khera (3111_CR33) 2023; 22 A Sadeghi (3111_CR78) 2013; 14 YC Ding (3111_CR69) 2019; 10 S Manimaran (3111_CR65) 2016; 32 G Choonoo (3111_CR18) 2019; 14 L Licitra (3111_CR10) 2011; 22 CH Chung (3111_CR28) 2004; 5 MJ Garnett (3111_CR21) 2012; 483 |
| References_xml | – volume: 483 start-page: 603 year: 2012 ident: 3111_CR20 publication-title: Nature doi: 10.1038/nature11003 – volume: 11 start-page: 1 year: 2010 ident: 3111_CR63 publication-title: Genome Biol. doi: 10.1186/gb-2010-11-3-r25 – volume: 11 start-page: 14755 year: 2021 ident: 3111_CR24 publication-title: Sci. Rep. doi: 10.1038/s41598-021-94259-5 – ident: 3111_CR47 doi: 10.1101/2020.07.25.20146431v1 – volume: 11 start-page: 42 year: 2023 ident: 3111_CR1 publication-title: Med. Sci. – volume: 22 start-page: 146 year: 2023 ident: 3111_CR33 publication-title: Mol. Cancer doi: 10.1186/s12943-023-01846-3 – volume: 7 start-page: e1001057 year: 2011 ident: 3111_CR66 publication-title: PLoS Comput. Biol. doi: 10.1371/journal.pcbi.1001057 – volume: 581 start-page: 434 year: 2020 ident: 3111_CR57 publication-title: Nature doi: 10.1038/s41586-020-2308-7 – ident: 3111_CR67 doi: 10.18637/jss.v046.i11 – volume: 26 start-page: 1619 year: 2021 ident: 3111_CR14 publication-title: Int. J. Clin. Oncol. doi: 10.1007/s10147-021-01949-1 – volume: 6 start-page: 36158 year: 2016 ident: 3111_CR71 publication-title: Sci. Rep. doi: 10.1038/srep36158 – ident: 3111_CR4 doi: 10.1101/2024.12.05.24318538 – ident: 3111_CR77 doi: 10.3389/fgene.2019.00004 – volume: 26 start-page: 139 year: 2010 ident: 3111_CR62 publication-title: Bioinformatics doi: 10.1093/bioinformatics/btp616 – volume: 562 start-page: 526 year: 2018 ident: 3111_CR19 publication-title: Nature doi: 10.1038/s41586-018-0623-z – volume: 483 start-page: 570 year: 2012 ident: 3111_CR21 publication-title: Nature doi: 10.1038/nature11005 – volume: 9 start-page: 26064 year: 2018 ident: 3111_CR22 publication-title: Oncotarget doi: 10.18632/oncotarget.25436 – volume: 173 start-page: 321 year: 2018 ident: 3111_CR34 publication-title: Cell doi: 10.1016/j.cell.2018.03.035 – volume: 22 start-page: 1078 year: 2011 ident: 3111_CR10 publication-title: Ann. Oncol. doi: 10.1093/annonc/mdq588 – ident: 3111_CR55 – ident: 3111_CR74 – volume: 14 start-page: 144 year: 2013 ident: 3111_CR78 publication-title: BMC Bioinform. doi: 10.1186/1471-2105-14-144 – ident: 3111_CR70 – ident: 3111_CR29 doi: 10.2202/1544-6115.1128 – volume: 73 start-page: 285 year: 2013 ident: 3111_CR39 publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-12-1906 – volume: 10 start-page: 557 year: 2019 ident: 3111_CR51 publication-title: Front. Pharmacol. doi: 10.3389/fphar.2019.00557 – volume: 7 start-page: 284ra257 year: 2015 ident: 3111_CR46 publication-title: Sci. Transl Med. doi: 10.1126/scitranslmed.3010564 – ident: 3111_CR13 doi: 10.3390/cancers12092691 – volume: 19 start-page: 1389 year: 2013 ident: 3111_CR11 publication-title: Nat. Med. doi: 10.1038/nm.3388 – volume: 5 start-page: 489 year: 2004 ident: 3111_CR28 publication-title: Cancer Cell. doi: 10.1016/S1535-6108(04)00112-6 – ident: 3111_CR75 – volume: 8 start-page: e56823 year: 2013 ident: 3111_CR27 publication-title: PLOS ONE doi: 10.1371/journal.pone.0056823 – volume: 32 start-page: 3836 year: 2016 ident: 3111_CR65 publication-title: Bioinformatics doi: 10.1093/bioinformatics/btw538 – volume: 375 start-page: 1856 year: 2016 ident: 3111_CR15 publication-title: N Engl. J. Med. doi: 10.1056/NEJMoa1602252 – volume: 12 start-page: 4681 year: 2021 ident: 3111_CR32 publication-title: Bioengineered doi: 10.1080/21655979.2021.1957754 – volume: 10 start-page: 198 year: 2019 ident: 3111_CR69 publication-title: Oncotarget doi: 10.18632/oncotarget.26559 – volume: 18 start-page: 1 year: 2017 ident: 3111_CR43 publication-title: BMC Genom. doi: 10.1186/s12864-017-3658-x – volume: 17 start-page: 1 year: 2016 ident: 3111_CR56 publication-title: Genome Biol. doi: 10.1186/s13059-016-0974-4 – volume: 14 start-page: e0223639 year: 2019 ident: 3111_CR18 publication-title: PLoS One doi: 10.1371/journal.pone.0223639 – volume: 13 start-page: 2498 year: 2003 ident: 3111_CR79 publication-title: Genome Res. doi: 10.1101/gr.1239303 – volume: 10 start-page: 540 year: 2019 ident: 3111_CR5 publication-title: Cell. Death Dis. doi: 10.1038/s41419-019-1769-9 – volume: 502 start-page: 333 year: 2013 ident: 3111_CR25 publication-title: Nature doi: 10.1038/nature12634 – volume: 359 start-page: 1116 year: 2008 ident: 3111_CR12 publication-title: N Engl. J. Med. doi: 10.1056/NEJMoa0802656 – volume: 20 start-page: 185 year: 2019 ident: 3111_CR80 publication-title: Genome Biol. doi: 10.1186/s13059-019-1758-4 – volume: 18 start-page: 551 year: 2017 ident: 3111_CR76 publication-title: Nat. Rev. Genet. doi: 10.1038/nrg.2017.38 – volume: 8 start-page: 118 year: 2007 ident: 3111_CR64 publication-title: Biostatistics doi: 10.1093/biostatistics/kxj037 – volume: 4 start-page: e1000117 year: 2008 ident: 3111_CR31 publication-title: PLoS Comput. Biol. doi: 10.1371/journal.pcbi.1000117 – volume: 7 start-page: 1 year: 2006 ident: 3111_CR73 publication-title: Genome Biol. doi: 10.1186/gb-2006-7-s1-s4 – ident: 3111_CR59 doi: 10.1002/0471142905.hg0720s76 – volume: 517 start-page: 576 year: 2015 ident: 3111_CR17 publication-title: Nature doi: 10.1038/nature14129 – volume: 560 start-page: 325 year: 2018 ident: 3111_CR44 publication-title: Nature doi: 10.1038/s41586-018-0409-3 – volume: 44 start-page: D862 year: 2016 ident: 3111_CR60 publication-title: Nucleic Acids Res. doi: 10.1093/nar/gkv1222 – ident: 3111_CR9 – volume: 10 start-page: 424 year: 2020 ident: 3111_CR36 publication-title: Cell. Syst. doi: 10.1016/j.cels.2020.04.007 – volume: 3 start-page: 146 year: 2014 ident: 3111_CR41 publication-title: F1000Res doi: 10.12688/f1000research.4431.2 – volume: 66 start-page: 7405 year: 2006 ident: 3111_CR42 publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-06-0186 – volume: 1 start-page: 417 year: 2015 ident: 3111_CR30 publication-title: Cell. Syst. doi: 10.1016/j.cels.2015.12.004 – ident: 3111_CR53 – volume: 41 start-page: D955 year: 2012 ident: 3111_CR35 publication-title: Nucleic Acids Res. doi: 10.1093/nar/gks1111 – volume: 10 start-page: 2138 year: 2019 ident: 3111_CR45 publication-title: Nat. Commun. doi: 10.1038/s41467-019-10148-6 – ident: 3111_CR49 doi: 10.1101/mcs.a005439 – volume: 29 start-page: 509 year: 2013 ident: 3111_CR40 publication-title: Bioinformatics doi: 10.1093/bioinformatics/btt003 – volume: 945 start-page: 161 year: 2013 ident: 3111_CR48 publication-title: Methods Mol. Biol. doi: 10.1007/978-1-62703-125-7_11 – volume: 31 start-page: 213 year: 2013 ident: 3111_CR54 publication-title: Nat. Biotechnol. doi: 10.1038/nbt.2514 – volume: 107 start-page: 16910 year: 2010 ident: 3111_CR72 publication-title: Proc. Natl. Acad. Sci. doi: 10.1073/pnas.1009843107 – ident: 3111_CR3 doi: 10.3390/cancers17030548 – volume: 263 start-page: 9 year: 2006 ident: 3111_CR7 publication-title: Eur. Arch. Otorhinolaryngol. doi: 10.1007/s00405-005-0961-y – volume: 40 start-page: 850 year: 2022 ident: 3111_CR61 publication-title: Cancer Cell. doi: 10.1016/j.ccell.2022.07.002 – volume: 84 start-page: 101977 year: 2020 ident: 3111_CR16 publication-title: Cancer Treat. Rev. doi: 10.1016/j.ctrv.2020.101977 – ident: 3111_CR2 – ident: 3111_CR38 doi: 10.1016/j.crmeth.2021.100039 – volume: 6 start-page: 92 year: 2020 ident: 3111_CR6 publication-title: Nat. Rev. Dis. Primers doi: 10.1038/s41572-020-00224-3 – volume: 38 start-page: 1085 year: 2017 ident: 3111_CR50 publication-title: Trends Pharmacol. Sci. doi: 10.1016/j.tips.2017.08.006 – volume: 17 start-page: 2060 year: 2018 ident: 3111_CR23 publication-title: Mol. Cancer Ther. doi: 10.1158/1535-7163.MCT-17-0733 – volume: 16 start-page: 284 year: 2012 ident: 3111_CR68 publication-title: Omics: J. Integr. Biology doi: 10.1089/omi.2011.0118 – volume: 375 start-page: 1109 year: 2016 ident: 3111_CR26 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMp1607591 – volume: 133 start-page: 2013 year: 2013 ident: 3111_CR8 publication-title: Int. J. Cancer doi: 10.1002/ijc.28112 – volume: 166 start-page: 740 year: 2016 ident: 3111_CR37 publication-title: Cell doi: 10.1016/j.cell.2016.06.017 – volume: 31 start-page: 3812 year: 2003 ident: 3111_CR58 publication-title: Nucleic Acids Res. doi: 10.1093/nar/gkg509 – ident: 3111_CR52 |
| SSID | ssj0000529419 |
| Score | 2.4514298 |
| Snippet | Even though head and neck squamous cell carcinoma (HNSCC) is the seventh most common cancer worldwide, there are only two PD-1 targeted immunotherapies... Abstract Even though head and neck squamous cell carcinoma (HNSCC) is the seventh most common cancer worldwide, there are only two PD-1 targeted... |
| SourceID | doaj proquest pubmed crossref springer |
| SourceType | Open Website Aggregation Database Index Database Publisher |
| StartPage | 19742 |
| SubjectTerms | 631/114 692/4028/67/1536 692/4028/67/69 Antitumor drug screening assays Cancer Cancer therapies Chemotherapy Copy number DNA Copy Number Variations Genes Genomics Genomics - methods Head and neck carcinoma Head and Neck Neoplasms - drug therapy Head and Neck Neoplasms - genetics HNSCC Humanities and Social Sciences Humans Immunotherapy Leukemia Multi-Omics multidisciplinary Mutation Patients PD-1 protein Pembrolizumab Precision Medicine Science Science (multidisciplinary) Squamous cell carcinoma Squamous Cell Carcinoma of Head and Neck - drug therapy Squamous Cell Carcinoma of Head and Neck - genetics Squamous Cell Carcinoma of Head and Neck - pathology Tumors |
| SummonAdditionalLinks | – databaseName: Biological Science Database dbid: M7P link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Jb9UwEB5BAYkLe2mgICNxg6iOPYmdU1WqVpyqHkDqzXIcBz2hJu3LK1J_Av-6HsdJhVguHJNYiZNZM9sH8L7wSlte2vCT43SONHzWcuty3QV12fC2dI5HsAl1cqLPzurTFHAbU1nlrBOjom4HRzHyPRlskyZULNy_uMwJNYqyqwlC4y7coykJMpbunS4xFspiYVGnXhku9d4Y7BX1lIkyD9xcFLn6xR7Fsf1_8jV_y5NG83P8-H83_gQeJceTHUyc8hTu-P4ZPJigKK-fw88p-xuezVZLjxYLmrpltm9Z7913Nl5eWYoUMIr2M0coRP1wblmazcrWU72tZ5uBTX1d1yzhALF5LEVgAzZ0jMzpFIWMt6dJsecrx6he9QV8PT76cvg5TzANuUOpN7mqsMbGe6FbWwqOBRaNEq3WXlSq47W1KJ0lV6JoXe2wIgwsoTTvGhEOtNyGrX7o_Q6wSthaqNpJ31h0RaedU9i0VnTBEdWoM_gwE8tcTNM4TMyiS20m0ppAWhNJa1QGn4iey0qapB1PDOtvJgmmKbnEFmUT9uHRilIHnsVSSdVgaRsuM9idyWqSeI_mlqYZvFsuB8Gk7297H0hBa6rgHSDWGbycuGjZCXJUsqp4Bh9ntrq9-d9f6NW_9_IaHorI2VXOy13Y2qyv_Bu4735sVuP6bRSNG8WnFO4 priority: 102 providerName: ProQuest |
| Title | Assessing individual head and neck squamous cell carcinoma patient response to therapy through integration of functional and genomic data |
| URI | https://link.springer.com/article/10.1038/s41598-025-03111-7 https://www.ncbi.nlm.nih.gov/pubmed/40473660 https://www.proquest.com/docview/3215883104 https://www.proquest.com/docview/3216362449 https://doaj.org/article/5034d43b683e4a2582c845737b45ab03 |
| Volume | 15 |
| WOSCitedRecordID | wos001504112500010&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: Acceso a contenido Full Text - Doaj customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: DOA dateStart: 20110101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: M~E dateStart: 20110101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVPQU databaseName: Biological Science Database customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: M7P dateStart: 20110101 isFulltext: true titleUrlDefault: http://search.proquest.com/biologicalscijournals providerName: ProQuest – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: 7X7 dateStart: 20110101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: BENPR dateStart: 20110101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Publicly Available Content Database customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: PIMPY dateStart: 20110101 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVPQU databaseName: Science Database customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: M2P dateStart: 20110101 isFulltext: true titleUrlDefault: https://search.proquest.com/sciencejournals providerName: ProQuest |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwEB5BC1IvqDwbWlZG4gZRHXsST44UtYJDVxECaTlZjuNIK9Qs7G6R-hP41_iR3RZRxIWLpSSOZXvGnvFjvg_gVeEUGV4av8ixlGMAnzXc2Jx6P122vCut5ZFsQk2nNJvVzQ2qr3AnLMEDp447LrnEDmVbkXRoREm-TCyVVC2Wpk04n97rubGYSqjeosaiHqNkuKTjlbdUIZpMlLnX46LI1W-WKAL23-Zl_nFCGg3P2T48GD1G9jbV9CHcccMjuJ84JK8ew890bOt_ZfNtcBXzU2zHzNCxwdmvbPX90oQlPgvb9MwG-qBhcWHYCKrKlumirGPrBUsBWVdsJPBhGzwJLz-26Fmwg2n7MBYfIF4v5paFi6ZP4PPZ6ad37_ORXyG3KGmdqwprbJ0T1JlScCywaJXoiJyoVM9rY1BaE3yAorO1xSqQVwlFvG-FfyD5FHaGxeAOgFXC1ELVVrrWoC16slZh2xnRew-SkDJ4velr_S3BaOh4_C1JJ8loLxkdJaNVBidBHNucAQI7vvCKoUfF0P9SjAyONsLU47hcaek9HArcapjBy-1nP6JC_5vBeVGEPJU364h1Bs-SEmxrghyVrCqewZuNVlwX_vcGPf8fDTqEPRHVt8p5eQQ76-WlewH37I_1fLWcwF01UzGlCeyenE6bj5M4Jnx6LpqQKp_uNh_Omy-_ADvWDHQ |
| linkProvider | Directory of Open Access Journals |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VLQguvB-BAkaCE0R17EnsHBDiVXXVdtVDkcrJOI6DVqhJu7sF7U_gz_AbGeexFeJx64FjEsty7G8e9njmA3iaeKUtTy1tcpyOMRSftdy6WFekLgteps7xlmxCTSb68DDfX4MfQy5MuFY56MRWUZeNC2fkm5Jskw6sWPjq-CQOrFEhujpQaHSw2PHLb7Rlm78cv6P1fSbE1vuDt9txzyoQO5R6EasMcyy8F7q0qeCYYFIoUWrtRaYqnluL0tlg-ZLS5Q6zQNkklOZVIehBS-r3AqwjgV2PYH1_vLf_cXWqE-JmmOR9dg6XenNOFjJksYk0JvlJklj9YgFbooA_ebe_RWZbg7d17X-bqutwtXet2etOFm7Amq9vwqWObHN5C7538W36VzZdZaExskUls3XJau--sPnJqQ1nISzEM5gLPEt1c2RZX32WzbobxZ4tGtZlri1Zz3TEhsIbBHTWVCw4DN05a9t9qIV7NHUs3Mi9DR_OZR7uwKhuan8PWCZsLlTupC8suqTSziksSisqcrU16gieD-Awx129EdPeE5DadFAyBCXTQsmoCN4E_Kxahlrh7Ytm9tn0qsekXGKJsqBxeLSEWpJKTJVUBaa24DKCjQFGpldgc3OGoQierD6T6gnzb2tPSxHaZOT_IOYR3O1QuxoJclQyy3gELwYYn3X-9x-6_--xPIbL2wd7u2Z3PNl5AFdEK1VZzNMNGC1mp_4hXHRfF9P57FEvmAw-nTfAfwI1qW-4 |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Jb9QwFH4qZREX9iVQwEhwgmgc-yV2DggBZURVNJoDSL0Zx3HQCDVpJ1PQ_AT-Er8OL8lUiOXWA8csshz7e0v8lg_gSWaF1DTX7ifHyBR981lNtUll49RlRevcGBrIJsRsJg8OyvkW_BhrYXxa5agTg6KuO-PPyCfc2SbpWbFw0gxpEfPd6cuj49QzSPlI60inESGyb9ff3O9b_2Jv1-31U8ambz-8eZcODAOpQS5XqSiwxMpaJmudM4oZZpVgtZSWFaKhpdbIjfZWMKtNabDw9E1MSNpUzF1I7sY9B-eFb1oe0gbnm_MdH0HDrBzqdCiXk97ZSl_PxvLUSVKWpeIXWxgoA_7k5_4Wow2mb3r1f160a3BlcLjJqygh12HLtjfgYqTgXN-E7zHq7b6bLDa1acRZqJrotiatNV9If3yi_QkJ8VEOYjz7UtsdajL0pCXLmGdsyaojsZ5tTQb-IzK243DwJ11DvBsRT1_D8L5D7uHCEJ-news-nsk63IbttmvtXSAF0yUTpeG20miyRhojsKo1a5wDLlEm8GwEijqKXUhUyB7gUkVYKQcrFWClRAKvPZY2b_oO4uFGt_ysBoWkcsqxRl65eVjULJdOVjEXXFSY64ryBHZGSKlBrfXqFE8JPN48dgrJr79urdsK_07hvCLEMoE7EcGbmSBFwYuCJvB8hPTp4H__oHv_nssjuORQrd7vzfbvw2UWBKxIab4D26vliX0AF8zX1aJfPgwSSuDTWaP7Jw1gdvc |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Assessing+individual+head+and+neck+squamous+cell+carcinoma+patient+response+to+therapy+through+integration+of+functional+and+genomic+data&rft.jtitle=Scientific+reports&rft.au=Daniel+Bottomly&rft.au=Chase+Mathieson&rft.au=Myles+Vigoda&rft.au=Sophia+Jeng&rft.date=2025-06-05&rft.pub=Nature+Portfolio&rft.eissn=2045-2322&rft.volume=15&rft.issue=1&rft.spage=1&rft.epage=14&rft_id=info:doi/10.1038%2Fs41598-025-03111-7&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_5034d43b683e4a2582c845737b45ab03 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2045-2322&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2045-2322&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2045-2322&client=summon |